Respiree is a Singapore-founded health tech company that builds AI/ML platforms for managing disease progression across the care continuum. Its 1Bio platform draws on electronic health record data and proprietary US-patented, FDA-cleared sensors to track patient trajectories longitudinally, and its solutions are available in the US, Australia and APAC, backed by CE marking, US FDA 510(k) and Australia TGA clearances. The company is led by founder and CEO Dr. Gurpreet Singh and operates from Singapore and a US headquarters at the Texas Medical Center Innovation in Houston.
1
Round
1
Industry
3
Tags
Sep 21, 2026
Latest raise
Funding activity · 1 round
Sep 21, 2026
$-1
Series A
Led by ClavystBio
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
